Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myeloma
Kumar, Shaji, Durie, Brian, Nahi, Hareth, Vij, Ravi, Dimopoulos, Meletios A., Kastritis, Efstathios, Terpos, Evangelos, Leleu, Xavier, Beksac, Meral, Goldschmidt, Hartmut, Hillengass, Jens, Su, Zhuo,Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2018.1459609
Date:
May, 2018
File:
PDF, 1.50 MB
english, 2018